Apyx Medical (APYX) Non-Current Deffered Revenue (2014 - 2026)

Apyx Medical has reported Non-Current Deffered Revenue for 12 years, with the latest figure at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deffered Revenue fell 5.28% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (down 5.28% YoY), and the FY2025 full-year result was $1.0 million, down 6.08% from the prior year.
• Non-Current Deffered Revenue for Q1 2026 stood at $1.1 million, up from $1.0 million in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $1.4 million in Q4 2022, with the low at $1.0 million in Q4 2025.
• Historically, Non-Current Deffered Revenue has averaged $1.2 million across 5 years, with a median of $1.2 million in 2023.
• Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue surged 62.11% — and 2023, when it fell 11.51%.
• Apyx Medical's Non-Current Deffered Revenue stood at $1.4 million in 2022, then decreased by 11.51% to $1.2 million in 2023, then fell by 10.27% to $1.1 million in 2024, then decreased by 6.08% to $1.0 million in 2025, then grew by 7.71% to $1.1 million in 2026.
• The last three Non-Current Deffered Revenue figures came in at $1.1 million (Q1 2026), $1.0 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.